boston scientific corp stock bsx slid 5 in premarket trade wednesday after the medical device maker missed profit estimates for the fourth quarter the company had net income of 126 million or 9 cents a share up from 80 million or 6 cents a share in the yearearlier period excluding onetime items adjusted eps came to 45 cents below the 47 cent factset consensus sales rose to 3242 billion from 3127 billion in line with the 3243 billion factset consensus the company said it had a negative impact of about 200 basis points associated with unplanned reserves set up for italian government payback provisions which shaved 4 cents off adjusted eps the company is now expecting firstquarter adjusted eps of 42 cents to 44 cents while factset is looking for 44 cents it expects fullyear adjusted eps of 186 to 193 compared with a factset consensus of 193 the stock is up 63 in the last 12 months while the sp 500 spx has fallen 10